RASSF4 downregulation has been implicated in several human cancers such as nasopharyngeal carcinoma, gastric adenocarcinoma, multiple myeloma and lung cancer.9, 10, 11, 12. The gene discussed is RASSF4; the disease is plasma cell myeloma.